Upadacitinib hemihydrate.
2 Inquiries
2050057-56-0
Shanghai
100g/bag
2025-05-01
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Upadacitinib hemihydrate
Other Name:Upadacitinib hemihydrate;UNII-NEW4DV02U5;NEW4DV02U5;2050057-56-0;Rinvoq (TN);Upadacitinib hydrate (JAN);D11048;(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide hydrate(2:1);1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-E)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, hydrate (2:1), (3S,4R)-;1831899-73-0
CAS No.:2050057-56-0
Molecular Formula:C34H40F6N12O3
InChIKeys:GJMQTRCDSIQEFK-SCDRJROZSA-N
Exact Mass:778.32505216
UNII:NEW4DV02U5
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
UPADACITINIB HEMIHYDRATE
225 G May 6, 2026 
South Korea
Upadacitinib Hemihydrate
100 G Mar 27, 2025 Post an enquiry for this product